MDSR 2024: Clinical Higher Risk MDS

Sdílet
Vložit
  • čas přidán 8. 07. 2024
  • Overview of the treatment for HR-MDS - Pierre Fenaux
    New drugs including Abs and BCL2-inhibitor for HRMDS -
    Guillermo Garcia-Manero
    Azacitidine Treatment - Yasuhito Nannya
    CLK inhibitor - Seishi Ogawa
    Transplantation or practical treatment for HR-MDS in Japan - Kensuke Usuki

Komentáře •